SARENA FRANCIS WILLARD (Chief Strategy Officer) exercised options at FIVE PRIME THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/15/2020ACC: 0001209191-20-063393
Officer· Chief Strategy Officer
Since Sep 2018
-11.58K
Net shares
Net seller
$186.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
22K acquired · 33.58K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22K
Price / share
—
Trade value
—
% of position
19.0%
12/11/2020
116.01K→138.01K
Common Stock
Direct
Shares
−11.58K
Price / share
$16.14
Trade value
$186.95K
% of position
8.4%
12/11/2020
138.01K→126.43K
Total
Net shares
+10.42K
Net value
-$186.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2020 | M · Option Exercise | +22K | — | — | 19.0% | 116.01K | 138.01K |
| Common Stock Direct | 12/11/2020 | F · Tax Withholding | −11.58K | $16.14 | $186.95K | 8.4% | 138.01K | 126.43K |
| Total | +10.42K | -$186.95K | ||||||
Derivative Transactions1
Performance-Based Restricted Common Stock
Direct
Converts to
Common Stock
22K shares
Shares
−22K
Strike price
Held after
0.00
Exercisable
—
12/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance-Based Restricted Common Stock Direct | Common Stock22K shares | 12/11/2020 | M · Option Exercise | −22K | — | 0.00 |